SEC Form 4 · accession 0001161697-16-000911
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary Ingenito
Officer — Chief Medical Officer
Period of report
Jun 15, 2016
Accepted (ET)
Jun 17, 2016 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $0.79 | Jun 15, 2016 | A | 50,000 | A | Jun 15, 2017 | Jun 15, 2023 | Common Stock | 50,000 | 350,000 | D |
| Options to purchase common stock | $0.79 | Jun 15, 2016 | A | 50,000 | A | Jun 15, 2018 | Jun 15, 2023 | Common Stock | 50,000 | 400,000 | D |